PBF Energy(STG) PEN

Penumbra, Inc. is a leading medical device company that designs, develops, manufactures, and markets innovative products for the treatment of vascular and neurovascular conditions. With a strong focus on advanced technology, Penumbra aims to improve patient outcomes through its comprehensive range of medical devices.

Products and Services

• Indigo System for power aspiration of thrombus
• Penumbra System, an integrated mechanical thrombectomy system
• Ruby Embolization Platform for peripheral applications

Growth Outlook

• Revenue increased to $390 million in Q2 2026, up from $375 million in Q1 2026
• Net income rose to $34.8 million in Q2 2026, reflecting strong operational efficiency
• Operating cash flow reached $46 million in Q2 2026, indicating robust cash generation

Financial Highlights

• Trailing twelve-month revenue of $1.5 billion, showcasing consistent growth
• Gross profit margin of 67.8% in Q2 2026, demonstrating strong pricing power
• Current ratio of 5.75, indicating strong liquidity position

Penumbra, Inc. has established itself as a key player in the medical device industry, particularly in the vascular and neurovascular sectors. The company's innovative products, such as the Indigo System and the Penumbra System, are designed to address critical medical needs, enhancing patient care and outcomes. Recent financial performance highlights a positive trajectory, with significant revenue growth and strong profitability metrics. The increase in operating cash flow further underscores the company's ability to generate cash from its operations, providing a solid foundation for future investments and growth initiatives. With a robust product portfolio and a commitment to innovation, Penumbra is well-positioned to capitalize on the growing demand for advanced medical devices.